Dr. Nieper's Revolution in Technology, Medicine and Society: Conversion of Gravity Field Energy

Dr. Nieper's Revolution in Technology, Medicine and Society - Conversion of Gravity Field Energy by Hans Alfred Nieper ISBN-13: 9783925188077 ISBN-10: 392518807X stated 1st Edition 1985 Publisher: MIT Verlag Hardcover 5.7 x 8.25 inches, 384 pages Hans Alfred Herbert Eugen Nieper (23 May 1928 – 21 October 1998) was a controversial German alternative medicine practitioner who devised "Nieper Therapy". He is best known for his claims to be able to treat cancer, multiple sclerosis, and other serious diseases. His therapy has been discredited as ineffective and unsafe. Born in Germany in 1928, Nieper was educated at Johann Gutenberg University and the University of Freiburg before earning his medical degree at the University of Hamburg. During his career, he served as director for the Department of Medicine at Silbersee Hospital in Hanover and for the German Society for Medical Tumour Treatment. He was also a president of the private club German Society of Oncology, which conducting research of alternative medicine in oncology. Nieper was among the first researchers to work with lithium orotate. Nieper also patented, along with Franz Kohler, Calcium 2-aminoethylphosphate (Calcium AEP), which he believed could be helpful in combating such diseases as juvenile diabetes, gastritis, ulcer, thyroiditis, Myocarditis and Hodgkin's Disease. However, there is no evidence from reputable clinical trials for the success of the "Nieper Regime" for treating multiple sclerosis utilizing Calcium AEP. The "Nieper Therapy" approach to cancer also uses Calcium AEP, along with selenium. It is based in part around Nieper's belief that cancer is rarer among sharks than other fish and his theory that the lower blood-sodium level of sharks may be the reason; it places among its primary goals the reduction of that sodium in cancer patients. Like his friends Dean Burk and Ernst T. Krebs jr., Nieper was an outspoken opponent of fluoridation. He died at the age of 70 from a stroke.